Scientists discover that SARS-CoV-2 spike protein remains in the brain and skull bone marrow for years post-infection, causing chronic inflammation and increasing neurodegenerative disease risk. The ...

Researchers from Helmholtz Munich and Ludwig-Maximilians-Universität (LMU) have identified a mechanism that may explain the neurological symptoms of Long COVID. The study shows that the SARS-CoV-2 ...

A novel AI-powered imaging technique developed by Prof. Ali Ertürk’s team provides new insights into how the SARS-CoV-2 spike protein affects the brain. The method renders organs and tissue samples ...

In December 2024, a rumor began spreading online that a team of researchers at Yale University had found the "spike protein" of the SARS-CoV-2 virus, which is responsible for the COVID-19 illness, in ...

Decisions made by researchers during the microliter, benchtop development of biotherapeutics made from monoclonal antibodies (mAb) and recombinant proteins often don’t scale to larger stirred tank ...

The German company BioNTech partnered with Pfizer to develop and test a coronavirus vaccine known as BNT162b2. A clinical trial demonstrated that the vaccine has an efficacy rate of 95 percent in ...

Synthetic and inexpensive to produce, aptamers are attractive alternatives to antibodies for biomedical diagnostics and therapeutics. When new aptamer binders are needed, for example, to detect a new ...